Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Daniel Mullins

Showing results (31-40 of 333) with videos related to

Pageof 34
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
"Back to the Future" With Value in HealthMichael F Drummond, C Daniel Mullins
Nature Reviews. Rheumatology|December 1, 2018
If patients are the true north, patient-centeredness should guide researchLaura E Schanberg, C Daniel Mullins
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Value Assessment at the Point of Care: Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient ValuesMelissa J Armstrong, C Daniel Mullins
Research in Social & Administrative Pharmacy : RSAP|September 14, 2014
The Affordable Care Act, health care reform, prescription drug formularies and utilization management toolsBrian L Ung, C Daniel Mullins
Current Medical Research and Opinion|May 13, 2011
Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseasesJunling Wang, Xianchen Liu, C Daniel Mullins
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Societal implications of the pharmacoeconomics of alpha1-antitrypsin deficiencyC Daniel Mullins, Lisa Blatt, Junling Wang
Current Opinion in Oncology|March 15, 2014
Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancerCandice Yong, Eberechukwu Onukwugha, C Daniel Mullins
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 20, 2012
Note from the editorsMichael Drummond, Mark Helfand, C Daniel Mullins
Journal of Managed Care & Specialty Pharmacy|October 30, 2014
Do value thresholds for oncology drugs differ from nononcology drugs?Yuna Hyo Jung Bae, C Daniel Mullins
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 16, 2008
Using cost-effectiveness analysis to sharpen formulary decision-making: the example of tiotropium at the Veterans Affairs health care systemEbere Onukwugha, C Daniel Mullins, Sylvain DeLisle
Pageof 34

Showing results (31-40 of 333) with videos related to

Sort By:
Pageof 34
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
"Back to the Future" With Value in HealthMichael F Drummond, C Daniel Mullins
Nature Reviews. Rheumatology|December 1, 2018
If patients are the true north, patient-centeredness should guide researchLaura E Schanberg, C Daniel Mullins
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Value Assessment at the Point of Care: Incorporating Patient Values throughout Care Delivery and a Draft Taxonomy of Patient ValuesMelissa J Armstrong, C Daniel Mullins
Research in Social & Administrative Pharmacy : RSAP|September 14, 2014
The Affordable Care Act, health care reform, prescription drug formularies and utilization management toolsBrian L Ung, C Daniel Mullins
Current Medical Research and Opinion|May 13, 2011
Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseasesJunling Wang, Xianchen Liu, C Daniel Mullins
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Societal implications of the pharmacoeconomics of alpha1-antitrypsin deficiencyC Daniel Mullins, Lisa Blatt, Junling Wang
Current Opinion in Oncology|March 15, 2014
Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancerCandice Yong, Eberechukwu Onukwugha, C Daniel Mullins
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 20, 2012
Note from the editorsMichael Drummond, Mark Helfand, C Daniel Mullins
Journal of Managed Care & Specialty Pharmacy|October 30, 2014
Do value thresholds for oncology drugs differ from nononcology drugs?Yuna Hyo Jung Bae, C Daniel Mullins
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 16, 2008
Using cost-effectiveness analysis to sharpen formulary decision-making: the example of tiotropium at the Veterans Affairs health care systemEbere Onukwugha, C Daniel Mullins, Sylvain DeLisle
Pageof 34